Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Argus Health
Deloitte
Accenture
Fish and Richardson
Chinese Patent Office
Mallinckrodt
Merck
UBS
Boehringer Ingelheim

Generated: February 21, 2018

DrugPatentWatch Database Preview

Carbinoxamine maleate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for carbinoxamine maleate and what is the scope of carbinoxamine maleate patent protection?

Carbinoxamine maleate
is the generic ingredient in three branded drugs marketed by Mcneil, Cypress Pharm, Mikart, Vintage Pharms, Tris Pharma Inc, Invagen Pharms, Mikart Inc, Mission Pharmacal Co, and Ortho Mcneil Pharm, and is included in twelve NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Carbinoxamine maleate has twenty-one patent family members in fourteen countries.

There are seven drug master file entries for carbinoxamine maleate. Seven suppliers are listed for this compound.
Summary for carbinoxamine maleate
Pharmacology for carbinoxamine maleate

US Patents and Regulatory Information for carbinoxamine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vintage Pharms CARBINOXAMINE MALEATE carbinoxamine maleate SOLUTION;ORAL 040814-001 Feb 26, 2008 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mikart CARBINOXAMINE MALEATE carbinoxamine maleate SOLUTION;ORAL 040458-001 Apr 25, 2003 AA RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Tris Pharma Inc KARBINAL ER carbinoxamine maleate SUSPENSION, EXTENDED RELEASE;ORAL 022556-001 Mar 28, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Cypress Pharm CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 090417-001 Aug 23, 2010 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Cypress Pharm CARBINOXAMINE MALEATE carbinoxamine maleate SOLUTION;ORAL 090418-001 May 4, 2010 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Tris Pharma Inc KARBINAL ER carbinoxamine maleate SUSPENSION, EXTENDED RELEASE;ORAL 022556-001 Mar 28, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Mikart Inc CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 207484-001 May 31, 2016 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mikart CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 040442-001 Mar 19, 2003 AA RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mission Pharmacal Co CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 090756-001 May 27, 2011 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ortho Mcneil Pharm CLISTIN carbinoxamine maleate TABLET;ORAL 008915-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for carbinoxamine maleate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,202,537 Modified release formulations containing drug-ion exchange resin complexes ➤ Sign Up
8,597,684 Modified release formulations containing drug-ion exchange resin complexes ➤ Sign Up
9,549,989 Modified release formulations containing drug-ion exchange resin complexes ➤ Sign Up
8,747,902 Modified release formulations containing drug-ion exchange resin complexes ➤ Sign Up
8,883,217 Modified release formulations containing drug-ion exchange resin complexes ➤ Sign Up
9,675,703 Modified release formulations containing drug - ion exchange resin complexes ➤ Sign Up
9,198,864 Modified release formulations containing drug-ion exchange resin complexes ➤ Sign Up
8,790,700 Modified release formulations containing drug-ion exchange resin complexes ➤ Sign Up
8,337,890 Modified release formulations containing drug-ion exchange resin complexes ➤ Sign Up
8,491,935 Modified release formulations containing drug-ion exchange resin complexes ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for carbinoxamine maleate

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Citi
Queensland Health
Cerilliant
Colorcon
Chinese Patent Office
Harvard Business School
Mallinckrodt
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot